Epidemiological data and medical care situation of patients with chronic inflammatory diseases in Germany: Real-world evidence on prevalence, disease combinations, care

被引:0
|
作者
Riemekasten, Gabriela [1 ]
Schmelz, Renate [2 ]
Schaekel, Knut [3 ]
Thaci, Diamant [4 ]
Schreiber, Stefan [5 ,6 ]
Roecken, Marit [7 ]
Bartz, Holger [7 ]
Ploner, Tina [8 ]
Liao, Ximing [8 ]
Weber, Valeria [9 ]
Manz, Karina C. [9 ]
Burkhardt, Harald [10 ]
Leipe, Jan [11 ]
机构
[1] Univ klinikum Schleswig Holstein, Klin Rheumatol & Klin Immunol, Lubeck, Germany
[2] Univ klinikum Carl Gustav Carus Dresden, Med Klin & Poliklin 1, Fetscherstr 74, D-01307 Dresden, Germany
[3] Univ klinikum Heidelberg, IZEH Interdisziplinares Zent chron entzundl Erkran, Heidelberg, Germany
[4] Univ Lubeck, Inst & Exzellenzzentrum Entzundungs Med, Lubeck, Germany
[5] Univ klinikum Schleswig Holstein, Klin Innere Med 1, Campus Kiel, Kiel, Germany
[6] Univ klinikum Schleswig Holstein, Inst Klin Molekularbiol, Campus Kiel, Kiel, Germany
[7] Janssen Cilag GmbH, Neuss, Germany
[8] InGef Inst Angew Gesundheitsforschung Berlin GmbH, Berlin, Germany
[9] IGES Inst GmbH, Berlin, Germany
[10] Univ klinikum Frankfurt, Goethe Univ Frankfurt Main, Fraunhofer Inst Translationale Med & Pharmakol ITM, Med Klin II Rheumatol, Frankfurt, Germany
[11] Univ klinikum Mannheim, V Med Klin, Sekt Rheumatol, Mannheim, Germany
来源
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2024年 / 83卷 / 07期
关键词
Immune-mediated inflammatory diseases; Health insurances accounting data; Retrospective cross-sectional analysis; Multidisciplinary approach; Efficiency of care; PSORIATIC-ARTHRITIS; BOWEL-DISEASE;
D O I
10.1007/s00393-023-01459-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Chronic inflammatory diseases (immune-mediated inflammatory diseases, IMID) can overlap or occur simultaneously due to clinical similarities. The resulting utilization of heathcare structures has not yet been investigated across disciplines but is of potential importance for optimizing the treatment of patients with IMID.<br />Aim of the work: Analysis of epidemiological data including utilization of care services in patients with selected IMIDs: psoriasis, psoriatic arthritis (PsA), rheumatoid arthritis (RA), ankylosing spondylitis, ulcerative colitis, Crohn's disease and connective tissue disease.<br />Material and methods: In a retrospective cross-sectional analysis based on health insurances accounting data with a sample of approximately 4 million insured persons, the prevalence of the abovementioned IMID and the frequency of IMID combinations were analyzed based on documented diagnoses (ICD-10 GM). The frequency of hospitalizations and utilization of outpatient physician contacts was recorded in predefined specialist disciplines (general medicine, dermatology, gastroenterology, rheumatology) and compared with an age-adjusted and gender-adjusted reference population.<br />Results: A total of 188,440 patients had at least 1 of the IMID diagnoses analyzed (4.7%), with an age peak of 61-70 years. The highest prevalence was observed for psoriasis (1.85%), followed by rheumatoid arthritis (1.38%). Combinations with at least one other IMID were relatively common (29%), with this being most common in patients with psoriatic arthritis (82.9%, of which 68.2% had psoriasis), followed by ankylosing spondylitis (27.5%) and Crohn's disease (21.6%). Compared to the reference population, patients with IMID were hospitalized more often and more frequently utilized the outpatient disciplines.<br />Discussion: The study results describe that IMIDs occur in combination and that the patients make comparatively more use of care structures of different disciplines. A multidisciplinary approach could increase the efficiency of care; an evaluation is still pending.
引用
收藏
页码:578 / 586
页数:9
相关论文
共 50 条
  • [41] UNDERAPPRECIATION OF DISEASE BURDEN IN FEMALE PATIENTS WITH AXIAL SPONDYLOARTHRITIS (AXSPA) IN REAL-WORLD CARE
    Starzyk, K.
    Meng, R.
    Kumparatana, P.
    VALUE IN HEALTH, 2022, 25 (12) : S451 - S451
  • [42] INPATIENT CARE COSTS AND ASSOCIATED REIMBURSEMENTS FOR PATIENTS WITH LEPTOMENINGEAL DISEASE: A REAL-WORLD ANALYSIS
    Ozair, Ahmad
    Mansouri, Alireza
    Grossman, Stuart
    NEURO-ONCOLOGY, 2024, 26
  • [43] Concomitant Medical Conditions and Total Cost of Care in Patients With Migraine: A Real-World Claims Analysis
    Polson, Michael
    Williams, Ted D.
    Speicher, Lindsay C.
    Mwamburi, Mkaya
    Staats, Peter S.
    Tenaglia, Andrew T.
    AMERICAN JOURNAL OF MANAGED CARE, 2020, 26 (01): : S3 - S7
  • [44] IMPACT OF ROFLUMILAST ON HEALTH CARE RESOURCE UTILIZATION AND COSTS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN REAL-WORLD SETTINGS
    Corman, S.
    Wan, Y.
    Sun, S. X.
    Gao, X.
    VALUE IN HEALTH, 2014, 17 (03) : A175 - A175
  • [45] The prognostic impact of smoking and BMI in interstitial lung diseases: real-world data from primary care
    Gonnelli, Francesca
    Eleangovan, Neva
    Smith, Ursie
    Navaratnam, Vydia
    Corte, Tamera J.
    Price, David B.
    Carter, Victoria
    Bonifazi, Martina
    Hubbard, Richard
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [46] Health care situation of patients with chronic pain after surgery in Germany - a secondary data analysis project
    Heyer, K. A.
    Spehr, C.
    Augustin, M.
    EXPERIMENTAL DERMATOLOGY, 2012, 21 (03) : e24 - e24
  • [47] Etanercept persistence in juvenile idiopathic arthritis up to adult care in patients in Germany: a real-world analysis
    Minden, Kirsten
    Horneff, Gerd
    Blum, Andreas
    Curiale, Cinzia
    Tarallo, Miriam
    Hudson, Nicholas
    Gray, Christen M.
    Cappelleri, Joseph C.
    Daly, Ana Cristina Hernandez
    RHEUMATOLOGY, 2019, 58
  • [48] Big Data Just Got Bigger: Implications of Real-World Evidence and Patient-Entered Data on Health Care and Health Care Policy
    George, Dana M.
    George, Aaron E.
    George, Kelly L.
    AMERICAN JOURNAL OF LIFESTYLE MEDICINE, 2020, 14 (01) : 40 - 42
  • [49] Real-world incidence of inflammatory bowel disease among patients with other chronic inflammatory diseases treated with interleukin-17a or phosphodiesterase 4 inhibitors
    Emond, Bruno
    Ellis, Lorie A.
    Chakravarty, Soumya D.
    Ladouceur, Martin
    Lefebvre, Patrick
    CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (10) : 1751 - 1759
  • [50] Spotlight commentary: A role for real-world evidence to inform the clinical care of patients with diabetes mellitus
    Leonard, Charles E.
    Flory, James H.
    Likic, Robert
    Ogunleye, Olayinka O.
    Wei, Li
    Wong, Ian
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (12) : 4549 - 4551